Title:
PHARMACEUTICAL COMPOSITION CONTAINING BROUSSOCHALCONE A AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF INFLAMMATORY BOWEL DISEASE
Document Type and Number:
WIPO Patent Application WO/2019/004788
Kind Code:
A2
Abstract:
The present invention relates to a pharmaceutical composition containing broussochalcone A as an active ingredient for prevention or treatment of inflammatory bowel disease. The pharmaceutical composition containing broussochalcone A as an active ingredient for prevention or treatment of inflammatory bowel disease of the present invention suppresses inflammation to ameliorate symptoms of weight loss, reduction in bowel length, diarrhea, and hemafecia, which result from inflammatory bowel disease, and has no side effects occurring in an existing drug medicine, and thus can be effectively used in the treatment of inflammatory bowel disease.
Inventors:
KIM YOON SOO (KR)
CHOI JIN WOO (KR)
LEE SAE JIN (KR)
CHOI JIN WOO (KR)
LEE SAE JIN (KR)
Application Number:
PCT/KR2018/007424
Publication Date:
January 03, 2019
Filing Date:
June 29, 2018
Export Citation:
Assignee:
FUGENBIOPHARMA CO LTD (KR)
International Classes:
A61K31/12; A23L33/10
Attorney, Agent or Firm:
FIRSTLAW P.C. (KR)
Download PDF: